May

May

Gateway's Impact Measurement in the Context of the NORDP 2017 Annual Research Development Conference

By Domarina Oshana, Ph.D. at 26 May 2017

Gateway's Impact Framework was presented at the 9th Annual National Organization of Research Development Professionals (NORDP) conference in Colorado by Domarina Oshana, Ph.D., Gateway's Director of Research and Grants.

0 comments posted

New Technique May Make Detecting and Diagnosing Melanoma Easier

By Administrator at 12 May 2017

A new technique developed by researchers at the University of Missouri could prove invaluable in detecting and diagnosing melanomas, including those that have spread, or metastasized.

0 comments posted

Gateway's Impact Measurement to be Highlighted at NORDP 2017 Annual Research Development Conference

By Admin at 5 May 2017

Gateway for Cancer Research is pleased to announce that Domarina Oshana, Ph,D., Gateway Research and Grants Director, has been chosen by NORDP (National Organization of Research Development Professionals) to present at their upcoming annual conference in Colorado on May 8-10, 2017.

0 comments posted

Aspirin Reduces Risk of Premature Death by Helping to Prevent Cancer

By Admin at 4 May 2017

Aspirin has long been suggested as a tool to reduce the risk of heart disease in some people, but long-term clinical trials evaluating it for this purpose turned up a lesser known, but equally exciting, potential benefit: cancer prevention.

0 comments posted

Golf with NFL Greats and Help Kids with Cancer

By Admin at 1 May 2017

Join Gateway on Monday, May 22 at Cog Hill Golf & Country Club as we team up with the NFL Alumni Association to help fund meaningful and breakthrough pediatric cancer clinical trials.

0 comments posted

    Categories

    Archive

    2018 2017 2016 2015
    99 cents of every dollar received directly funds cancer clinical trials

    57

    Current Gateway-funded clinical trials

    150+

    Clinical trials funded at leading institutions worldwide

    $16.56

    Funds one patient for one day at a Gateway-funded clinical trial

     
     

    Mission Partners